ReviewBritish journal of pharmacology2020

Repositioning PARP inhibitors for SARS-CoV-2 infection(COVID-19); a new multi-pronged therapy for acute respiratory distress syndrome?

Nicola Curtin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.